Литература
1. Гусев Е.И., Скворцова В.И., Стаховская Л.В.,
Киликовский В.В. Проблема Инсульта в Российской Фе-
дерации. Качество жизни. Медицина 2006. № 2: 10–14.
2. Гусев Е.И., Скворцова В.И., Стаховская Л.В.,
Киликовский В.В., Айриян Н.Ю. Эпидемиология ин-
сульта в России. Consilium Medicum, 2003. Неврология:
5–7.
3. Гусев Е.И. Проблема инсульта в России. Ин-
сульт, приложение к журналу «Неврология и психиатрия
им. С.С. Корсакова». Медицина. 2003. № 9: 3–5.
4. Гусев Е.И., Скворцова В.И., Стаховская Л.В.,
Проблема инсульта в Российской Федерации: вре-
мя активных действий. Неврология и психиатрия им.
С.С. Корсакова. Медицина. 2007. № 8: 4–10.
5. Кузнецов А.Н., Кучеренко С.С., Виноградов О.И.,
Боломатов Н.В. Реперфузионная терапия при ишемиче-
ском инсульте. Болезни сердца и сосудов. Медиа Меди-
ка. 2008. № 3: 12–17.
6. Скворцова В.И. Комплекс мероприятий по со-
вершенствованию медицинской помощи больным с
сосудистыми заболеваниями в Российской Федерации.
Болезни сердца и сосудов. Медиа Медика. 2008. № 3:
4–6.
7. Суслина З.А. Ишемический инсульт: принципы
лечения в острейшем периоде. Атмосфера. Нервные бо-
лезни 2004; 1: 14–18.
8. Танашян М.М. Реперфузионная терапия при
ишемических нарушениях мозгового кровообращения.
Атмосфера. Нервные болезни. 2004; 1: 26–32.
9. Agyeman O., Nedeltchev K., Arnold M. et al. Time
to admission in acute ischemic stroke and transient ischemic
attack. Stroke 2006; 37:963–966.
10. Barret-Connor E., Khaw K. Diabetes mellitus; an
independent risk factor for stroke. Am. J. Epidemiol. 1988; 128:
116–124.
11. Becker K., Fruin M., Gooding T. et al. Communitybased
education improves stroke knowledge. Cerebrovasc Dis.
2001; 11(1): 34–43.
12. Davis P., Dambrosia J., Schoenberg B. et al. Risk
factors for ischemic stroke: a prospective study in Rochester,
Minnesota. Ann Neurol. 1987; 22(3): 319–27.
13. Gupta A., Thomas P. Knowledge of stroke is lacking
[letter]. BMJ. 2002; 325:392.
14. Harraf F., Sharma A., Brown M. et al. A multicentre
observational study of presentation and early assessment of
acute stroke. BMJ 2002; 325:17–21.
15. Hennerici M., Bogousslavsky J., Sacco R., Churchill’s
In clinical practice series: Stroke. Elsevier 2005:13.
16. Iso H., Jacobs Dr Jr., Wentworth D. et al. Serum
cholesterol levels and six-year mortality from stroke in 350,977
men screened for the multiple risk factor intervention trial. N
Engl J Med 1989 vol 320 p. 904–910.
17. Kamran S., Bener A., Deleu D., Khoja W. et al.
The level of awareness of stroke risk factors and symptoms in
the Gulf Cooperation Council countries: Gulf Cooperation
Council stroke awareness study. Neuroepidemiology. 2007;
29(3-4):235-42.
18. Kawachi I., Colditz G.A., Stampfer M.J., Willett
W.C., Manson J.E., Rosner B., Speizer F.E., Hennekens C.H.:
Smoking cessation and decreased risk of stroke in women.
JAMA 1993; 269:232-6.
19. Koenig K.L., Whyte E.M., Munin M.C., O'Donnell
L., Skidmore E.R., Penrod L.E., Lenze E.J. Stroke-related
knowledge and health behaviors among poststroke patients in
inpatient rehabilitation. Arch Phys Med Rehabil. 2007 Sep;
88(9):1214-6.
20. Lewington S., Clarke R., Qizilbash N., Peto R.,
Collins R.: Age-specific relevance of usual blood pressure to
vascular mortality: A meta-analysis of individual data for one
million adults in 61 prospective studies. Lancet 2002; 360:1903-
1913.
21. Lindegard B., Hillbom M. Associations between
brain infarction, diabetes, and alcoholism: observations from
the Gothenberg population cohort study. Acta Neurol Scand
1987; 75: 195-200.
22. McCabe P.J., Schad S., Hampton A., Holland D.E.,
Knowledge and self-management behaviors of patients with
recently detected atrial fibrillation. Heart Lung. 2008 Mar-
Apr; 37(2):79-90.
23. Neal B., MacMahon S., Chapman N.: Effects of ace
inhibitors, calcium antagonists, and other blood-pressurelowering
drugs: Results of prospectively designed overviews of
randomised trials. Blood pressure lowering treatment trialists'
collaboration. Lancet 2000; 356:1955-1964.
24. Nicol M., Thrift A. Knowledge of Risk Factors and
Warning Signs of Stroke. Vasc Health Risk Manag. 2005 June;
1(2): 137–147.
25. Pancioli A.M., Broderick J., Kothari R., Brott
T., Tuchfarber A., Miller R., Khoury J., Jauch E., Public
perception of stroke warning signs and knowledge of potential
risk factors., JAMA. 1998; 279(16):1288-92.
26. Pandian J.D., Jaison A., Deepak S.S., Kalra G.,
Shamsher S., Lincoln D.J., Abraham G. Public awareness of
warning symptoms, risk factors, and treatment of stroke in
northwest India. Stroke. 2005; 36(3):644-8.
27. Parahoo K., Thompson K., Cooper M., et al.
Stroke: awareness of the signs, symptoms and risk factors – a
population-based survey. Cerebrovasc Dis. 2003; 16:134–40.
28. Pontes-Neto O.M., Silva G.S., Feitosa M.R., de
Figueiredo N.L., Fiorot J.A. Jr., Rocha T.N., Massaro A.R.,
Leite J.P.. Stroke awareness in Brazil: alarming results in a
community-based study. Stroke. 2008; 39(2):292-6. Epub 2007
Dec 27.
29. Prospective Studies Collaboration. Cholesterol,
diastolic blood pressure, and stroke: 13000 strokes in 450000
people in 45 prospective cohorts. Lancet 1995 ; 346: 1647 –
1653.
30. Reeves M.J., Hogan J.G., Rafferty A.P., Knowledge of
stroke risk factors and warning signs among Michigan adults.
Neurology. 2002; 59(10):1547-52.
31. Rowe A.K., Frankel M.R., Sanders K.A. Stroke
awareness among Georgia adults: epidemiology and
considerations regarding management. South Med J. 2001;
94:613–18.
32. Sacco R.L., Benson R.T., Kargman D.E., Boden-
Albala B., Tuck C., Lin I.F., Cheng J.F., Paik M.C., Shea S.,
Berglund L. High-density lipoprotein cholesterol and ischemic
stroke in the elderly: the Northern Manhattan Stroke Study.
JAMA. 2001; 285(21):2729-35.
33. Samsa G.P., Cohen S.J., Goldstein L.B., et al.
Knowledge of risk among patients at increased risk for stroke.
Stroke. 1997;28:916–21.
34. Schneider A.T., Pancioli A.M., Khoury J.C., et al.
Trends in community knowledge of the warning signs and risk
factors for stroke. J Am Med Assoc. 2003; 289:343–6.
35. Staessen J., Fagard R., Thijs L., Celis H., Arabidze G.,
Birkenhager W., Bulpitt C., de Leeuw P., Dollery C., Fletcher
A., Forette F., Leonetti G., Nachev C., O'Brien E., Rosenfeld
J., Rodicio J., Tuomilehto J., Zanchetti A.: Randomised
double-blind comparison of placebo and active treatment for
older patients with isolated systolic hypertension. The systolic
hypertension in Europe (Syst-Eur) trial investigators. Lancet
1997; 350:757-764.
36. Wein T.H., Staub L., Felberg R., Hickenbottom S.L.,
Chan W., Grotta J.C., Demchuk A.M., Groff J., Bartholomew
L.K., Morgenstern L.B.: Activation of emergency medical
services for acute stroke in a nonurban population: The t.L.L.
Temple foundation stroke project. Stroke 2000; 31:1925-1928.
37. Wolf P., D`Agostino R., Belanger A, Kannel W.,
Probability of stroke: a risk profile from Framingham Study.
Stroke 1991; 22:312 – 318.
38. Wolf P.A., D'Agostino R.B., Kannel W.B., Bonita R.,
Belanger A.J.: Cigarette smoking as a risk factor for stroke. The
Framingham study. JAMA 1988; 259:1025-1029.
39. Yoon S.S., Heller R.F., Levi C., et al. Knowledge and
perception about stroke among an Australian urban population.
BMC Public Health. 2001a;1:14.
40. Yoon S.S., Heller R.F., Levi C., et al. Knowledge and
stroke risk factors, warning symptoms, and treatment among
an Australian urban population. Stroke. 2001b; 32:1926–30.